News & Analysis as of

Opioid Medicaid Substance Abuse

Foley & Lardner LLP

Substance Use Disorder Treatment Services: 2025 Physician Fee Schedule Proposed Rule Would Expand Access and Medicare Coverage

Foley & Lardner LLP on

On July 10, the Centers for Medicare & Medicaid Services (CMS) released the Medicare Physician Fee Schedule Proposed Rule (Proposed Rule) for the calendar year 2025. The Proposed Rule would implement certain provisions of the...more

McAfee & Taft

2024 Oklahoma legislative session in review: Healthcare edition

McAfee & Taft on

By Cori H. Loomis While the healthcare industry was not a specific area of focus for this year’s Oklahoma legislative session as it has been in previous years when Medicaid reform and managed care were addressed, a number of...more

Manatt, Phelps & Phillips, LLP

[Webinar] Improving Access to Care for Pregnant and Postpartum People With Opioid Use Disorder - March 5th, 2:00 pm - 3:00 pm ET

In recent years, drug-related overdoses have become a leading cause of death during pregnancy and the postpartum period, exacerbating a mounting maternal mortality crisis and underscoring the need for improved access to care...more

Manatt, Phelps & Phillips, LLP

Access to Care for Justice-Involved Pregnant People With a Substance Use Disorder

There is a critical need to increase access to evidence-based care for justice-involved pregnant people with a substance use disorder (SUD)—and connect them to continued coverage and care upon release—according to national...more

Manatt, Phelps & Phillips, LLP

[Webinar] Access to Care for Justice-Involved Pregnant People With a Substance Use Disorder - May 1st, 2:00 pm - 3:00 pm ET

In a new webinar, Manatt Health, the American Medical Association (AMA) and a panel of stakeholders will share key lessons for states seeking to innovate and expand access to evidence-based care for pregnant people with a...more

McGuireWoods Consulting

Washington Healthcare Update - July 2021 #1

This week in Washington: Senate in recess, conversations continue on infrastructure and administration’s health initiatives. ...more

Manatt, Phelps & Phillips, LLP

National Roadmap on State-Level Efforts to End the Drug Overdose Epidemic

Editor’s Note: The American Medical Association (AMA) and Manatt Health released a national roadmap in September 2019 to guide policymakers in taking action to help end the nation’s opioid epidemic. Based largely on in-depth...more

Foley & Lardner LLP

COVID-19 Compounds Opioid Crisis and Treatment Gaps for Vulnerable Americans: Will a Biden Administration and New Congress Expand...

Foley & Lardner LLP on

Payment misalignment in Medicare FFS for Substance Use Disorder (SUD) treatment as the subject of potential legislative and/or regulatory reforms - New opportunities for investor-backed behavioral health platforms in...more

Manatt, Phelps & Phillips, LLP

[Webinar] National Roadmap on State-Level Efforts to End the Drug Overdose Epidemic - February 9th, 2:00 pm - 3:00 pm ET

How Can Mental Health and Substance Use Disorder (SUD) Parity Laws Help Battle the Overdose Epidemic? Learn the Answers—and Catch Up on the Most Recent State and Federal Developments—at a New Webinar from the AMA and Manatt. ...more

Manatt, Phelps & Phillips, LLP

State Strategies to Support Access to SUD Treatment Services Through the COVID-19 Pandemic

Editor’s Note: Prior to the COVID-19 pandemic, many governors were looking for ways to strengthen substance use disorder (SUD) provider capacity as part of their comprehensive response to the opioid epidemic. With the...more

Chambliss, Bahner & Stophel, P.C.

Medicare Now Covers Outpatient Treatment for Opioid Addiction

Recognizing the huge problems caused by opioid addiction in the United States, Medicare is adding a new outpatient opioid treatment benefit, paying for methadone and related treatment in certain facilities. Under a new...more

Manatt, Phelps & Phillips, LLP

Using Medicaid to Advance Evidence-Based Treatment of Substance Use Disorders: A Toolkit for State Medicaid Leaders

In 2019, the number of drug overdose deaths in the United States declined, suggesting that the efforts of state and local governments, providers and other stakeholders to stem the crisis of drug-related deaths are beginning...more

Manatt, Phelps & Phillips, LLP

Roadmap on State-Level Efforts to End the Opioid Epidemic

Editor’s Note: Manatt Health and the American Medical Association (AMA) have partnered to create the “National Roadmap on State-Level Efforts to End the Opioid Epidemic: Leading-Edge Practices and Next Steps.” The roadmap is...more

Manatt, Phelps & Phillips, LLP

National Roadmap on State-Level Efforts to End the Opioid Epidemic

The American Medical Association (AMA) and Manatt Health recently undertook an in-depth analysis of the response to the opioid epidemic by 4 states: Colorado, Mississippi, North Carolina, and Pennsylvania. The analysis...more

Manatt, Phelps & Phillips, LLP

Spotlight on North Carolina: Ending the Opioid Epidemic

North Carolina has fought the opioid epidemic with an array of public- and private-sector initiatives. In 2017, Governor Roy Cooper released the state’s Opioid Action Plan developed in collaboration with community partners....more

Holland & Hart - Health Law Blog

What Healthcare Providers Need to Know About EKRA

In October 2018, the President signed the SUPPORT for Patients and Communities Act, a portion of which is known as the “Eliminating Kickbacks in Recovery Act of 2018” or “EKRA.” EKRA, aimed at the ongoing opioid crisis, is...more

Manatt, Phelps & Phillips, LLP

Medicaid Provisions in the SUPPORT Act

Editor’s Note: In October, President Trump signed into law the Substance Use Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (the SUPPORT Act). In a new article for The...more

Bass, Berry & Sims PLC

Congress Takes Action to Curb the Opioid Crisis

Bass, Berry & Sims PLC on

In a bipartisan effort to combat the opioid crisis, H.R. 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (the Act), was enacted on October 24,...more

McGuireWoods Consulting

New Opioid Law Has Implications for MA, Medicaid Plans

This AIS Health article quotes McGuireWoods Attorney Stephanie Kennan. One year after the Trump administration declared the opioid crisis a public health emergency, the president on Oct. 24 signed The SUPPORT for Patients...more

Mintz - Health Care Viewpoints

Final Opioid Legislation Expands Treatment Options for Medicaid Beneficiaries with Substance Use Disorder

The final bipartisan opioid package, which passed in the Senate this week and is expected to be signed into law, includes a significant revision from the original House bill that could lead to an increase in treatment options...more

K&L Gates LLP

The Opioid Epidemic: The IMD CARE Act and Other Proposals to Expand Services

K&L Gates LLP on

A bill to temporarily lift the restriction on federal Medicaid funding for certain substance use disorder (“SUD”) services to adults between ages 21 and 64 in an institution for mental disease (“IMD”) passed the House on June...more

Foley & Lardner LLP

Health Care Policy Newsletter - July 2018

Foley & Lardner LLP on

Foley & Lardner LLP’s (“Foley”) Bipartisan Public Policy Team is pleased to share our “Public Policy Weekly* Health Care Newsletter” in which we compile the latest Health care policy news and legislation. *Please note that we...more

Alston & Bird

Alston & Bird Healthcare Week in Review

Alston & Bird on

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

Mintz - Health Care Viewpoints

Opioids Have Our Attention

The government is focusing on opioids. Whether it be program policies, enforcement, or legislation, combating the opioid epidemic continues to be a major focus for government officials. It is also a major piece of the...more

Foley & Lardner LLP

Health Care Policy Newsletter - June 2018 pt 2

Foley & Lardner LLP on

Foley & Lardner LLP’s (“Foley”) Bipartisan Public Policy Team is pleased to share our “Public Policy Weekly* Health Care Newsletter” in which we compile the latest Health care policy news and legislation. *Please note that we...more

34 Results
 / 
View per page
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide